Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): James A Reiffel Added: 1 year ago

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Overview of Genetic Risk Factors and Aetiologies
Author(s): Sarah Ming Li Tan , Shir Lynn Lim , Marcus EH Ong , et al Added: 6 months ago

Electrophysiology & Arrhythmia

Heart Failure
Sudden Cardiac Death Risk in Newly Diagnosed Heart Failure: SCD-PROTECT
Author(s): Marat Fudim , David Duncker Added: 3 weeks ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19… View more

Electrophysiology & Arrhythmia

Heart Failure
Aortic Atherosclerosis as a Predictor of LAA Thrombus
Author(s): Samah AlKharji , Mohamed Al Rawahi , Ahmed AlTurki , et al Added: 6 months ago

Anticoagulation

Electrophysiology & Arrhythmia
Heart Disease in Pregnancy: Maternal and Neonatal Risk
Author(s): Rofila Dita Karmia , Mefri Yanni , Yusrawati , et al Added: 2 months ago

Inherited and Congenital Cardiac Conditions

Electrophysiology & Arrhythmia
EASD 2025 Highlights: Updates on Icosapent Ethyl and Cardiometabolic Risk
Author(s): Rahul Aggarwal , Dirk Müller-Wieland Added: 5 months ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type… View more

Heart Failure

Prevention & Chronic Conditions
EASD 23: Epidemiologic Trends & Disparities in Diabetes Risk Among LGBTQ+ Population
Author(s): Carl Streed Added: 2 years ago
EASD 2023 – Dr Carl G Streed (Boston University School of Medicine, US) joins us to summarise healthcare disparities among the LGBTQ+ population.In this interview, Dr Streed discusses the available evidence and explains the minority stress model. This model suggests that experiences of discrimination and stress contribute to worse health outcomes in the LGBTQ community. This can lead to mental… View more

Demographic

Prevention & Chronic Conditions
Risk Stratification in Arrhythmogenic Mitral Valve Prolapse
Author(s): James N Cameron , Kadhim I Kadhim , Suraya HB Kamsani , et al Added: 1 year ago

Electrophysiology & Arrhythmia
PFA Safety Profile Assessed in Over 40,000 Patients
Added: 1 month ago Source:  Radcliffe Cardiology
Pulsed field ablation (PFA) is an emerging energy source for atrial fibrillation (AF) ablation, noted for its potential safety benefits, including a lower risk of injury to surrounding tissues. A large, real-world study has now provided extensive data on the safety of this technology in a broad patient population.¹Mechanism of ActionPFA utilises pulsed electric fields to create pores in cell… View more

Electrophysiology & Arrhythmia
EHRA 24: Insights from an ARTESiA Substudy
Author(s): William McIntyre Added: 1 year ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk… View more

Electrophysiology & Arrhythmia